The full TRIUMPH program enrolled more than 5,800 participants across multiple Phase 3 trials
While our recent report has shown that over 7% of all prescriptions are for GLP-1-based therapies ( 8 ), oral formulations may lower barriers to initiation by offering a non-injectable option that can be prescribed and managed in a broader range of clinical settings
Weekly measurements: Body weight at the same time each week Waist and hip circumference Side effect severity (0-10 scale) Energy levels (0-10 scale) Appetite level (0-10 scale) Monthly assessments: Progress photos from consistent angles Body fat estimates if available Overall protocol satisfaction Any notable changes in health markers SeekPeptides members access comprehensive tracking templates and progress visualization tools that simplify this documentation process
Delivery services are fast and efficient
Weigert, C., Brodbeck, K., Lehmann, R., Haring, H
Verified 99% HPLC purity